AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2021
Sep 10, 2021
29755_dirs_2021-09-10_73ea95a7-1da6-4ca6-99b6-d7c90412ca94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-09-01
Reporting Person: Schumacher Laura J (Vice Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-01 | Common Stock, $0.01 par value | G | 1250 | — | Disposed | 213003 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4